Why I think Ramsay Health Care Limited shares are a buy

Whilst there are countless quality options for investors in the healthcare sector, one of the best in my opinion would have to be private hospital operator Ramsay Health Care Limited (ASX: RHC).

Although the Ramsay Health Care share price performance was a bit of a disappointment in 2017, I’m confident things will be much better this year.

Last year Ramsay’s shares provided a return of about 4% including dividends. While this isn’t terrible, it pales in comparison to the gains made by healthcare sector peers CSL Limited (ASX: CSL), Medical Developments International Ltd (ASX: MVP), and Pro Medicus Limited (ASX: PME).

Why did Ramsay underperform its peers?

The surprise retirement of its long-serving CEO Chris Rex, falling private health insurance participation rates, and weaker-than-expected FY 2018 guidance have all weighed on its shares over the last 12 months.

As has the decision by Charlie Aitken’s AIM Global High Conviction fund to short its shares. Mr Aitken believes Ramsay is expensive for its growth profile and is subject to regulatory risks.

While I do agree that Ramsay is reasonably expensive at 30x trailing earnings given its FY 2018 profit growth guidance of 8% to 10%, I do feel it deserves to trade at a premium to the market-average due to its strong long-term growth prospects.

There are few shares on the local market which stand to profit as greatly as Ramsay from ageing populations and increased chronic disease burden around the world.

As a result of these tailwinds, its global footprint, and ability to expand through acquisitions or brownfield expansions, I believe Ramsay is capable of delivering above average earnings growth for the foreseeable future.

In my opinion, this makes it well worth considering Ramsay as a long-term buy and hold investment. It may not provide market-beating returns every year, but over the long-term I expect it to vastly outperform the market.

Here are three more top shares that have the potential to be market-beaters.

Top 3 ASX Blue Chips To Buy In 2018

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2018."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended PRO Medicus Ltd. The Motley Fool Australia has recommended Ramsay Health Care Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!